Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. BE

Go back to Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)
COGENT (NASDAQ: COGT) Delayed: 34.76 -0.19 (0.54%)
Previous Close $34.95    52 Week High $5.57 
Open $34.56    52 Week Low $2.90 
Day High $35.20    P/E 158.00 
Day Low $34.42    EPS $0.22 
Volume 784,081